<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Urinary incontinence — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Urinary incontinence (women)</h1>
        <div class="sub">Primary care: categorise (stress / urgency-OAB / mixed), do the minimum sensible workup (urine dip + exam where indicated), start first-line conservative care (PFMT / bladder training / lifestyle), and know when to refer.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑09</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key points for a GP-facing pathway page</strong>
                <ul>
                  <li>At first assessment, <strong>categorise urinary incontinence</strong> as stress, urgency urinary incontinence/overactive bladder (OAB), or mixed; in mixed, treat the <strong>predominant symptom</strong> first (NICE NG123).</li>
                  <li>Initial baseline: <strong>urine dipstick</strong> for blood/glucose/protein/leukocytes/nitrites; treat/confirm UTI only when appropriate (NICE NG123).</li>
                  <li>Use a <strong>3-day bladder diary</strong> in initial assessment of urinary incontinence/OAB (NICE NG123).</li>
                  <li>First-line conservative management:
                    <ul>
                      <li><strong>Stress (or mixed):</strong> supervised <strong>pelvic floor muscle training (PFMT)</strong> for ≥3 months (NICE NG123).</li>
                      <li><strong>Urgency/OAB (or mixed):</strong> <strong>bladder training</strong> for ≥6 weeks (NICE NG123) + lifestyle measures.</li>
                    </ul>
                  </li>
                  <li>If medicines are used for OAB: counsel that benefit may take <strong>≥4 weeks</strong>; review at 4 weeks; consider anticholinergic burden/cognition risk; consider beta‑3 agonist options if antimuscarinics unsuitable/ineffective (NICE NG123 + TA guidance).</li>
                  <li>Consider referral to specialist services for red-flag patterns (pain, voiding difficulty/retention, suspected fistula, neurological disease, faecal incontinence, pelvic mass), or after failed/tolerated conservative + medicine trials (NICE NG123).</li>
                </ul>
              </div>

              <h4>Assessment themes (primary care)</h4>
              <ul>
                <li><strong>Type of symptoms:</strong> stress (cough/laugh/exertion), urgency/OAB (urgency +/- frequency/nocturia), mixed (predominant symptom).</li>
                <li><strong>Contributors:</strong> pregnancy/childbirth, menopause/atrophy, obesity, constipation, chronic cough, high caffeine, meds (diuretics), mobility/cognitive impairment.</li>
                <li><strong>Examination (when indicated):</strong> abdominal and pelvic exam if needed to exclude pelvic mass/prolapse; check for atrophic changes if GSM suspected; assess pelvic floor muscle contraction before supervised PFMT (digital assessment recommended by NICE).</li>
                <li><strong>Tests:</strong> urine dip in all; MSU culture guided by symptoms + dip results (NICE NG123). Consider PVR (bladder scan) if voiding dysfunction symptoms or recurrent UTI; use bladder diary (≥3 days).</li>
                <li><strong>Do not routinely:</strong> imaging (CT/MRI/US except residual), cystoscopy, pad tests, or urodynamics prior to primary surgery when straightforward stress UI demonstrated (NICE NG123; specialist decision).</li>
              </ul>

              <h4>Conservative management (first-line)</h4>
              <ul>
                <li><strong>Stress / mixed:</strong> supervised PFMT ≥3 months; typical programme: ≥8 contractions, 3 times/day; continue if beneficial (NICE NG123).</li>
                <li><strong>Urgency/OAB / mixed:</strong> bladder training ≥6 weeks; consider adding medicine if bladder training insufficient and frequency troublesome (NICE NG123).</li>
                <li><strong>Lifestyle:</strong> reduce caffeine (OAB); fluid optimisation if too high/low; weight loss if BMI &gt;30; manage constipation; address cough/smoking (NICE NG123).</li>
                <li><strong>GSM/atrophy:</strong> consider vaginal oestrogen if OAB symptoms + GSM (NICE NG123).</li>
                <li><strong>Containment products:</strong> not a treatment; can be used as coping strategy pending definitive care, adjunct, or long-term only after treatment options explored; ensure annual review (NICE NG123).</li>
              </ul>

              <div class="callout warn">
                <strong>Local (D&amp;G)</strong>
                <ul>
                  <li>Likely destinations vary by local service: <strong>continence nurse / pelvic floor physio / urogynaecology / urology</strong>. This page includes a <em>Local agreement needed</em> list to avoid blocking drafting.</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">These snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;Urinary incontinence is leakage of urine. In primary care, categorise symptoms as &lt;strong&gt;stress&lt;/strong&gt;, &lt;strong&gt;urgency/overactive bladder (OAB)&lt;/strong&gt; or &lt;strong&gt;mixed&lt;/strong&gt; (treat the predominant symptom first).&lt;/li&gt;
  &lt;li&gt;Initial management is usually conservative: pelvic floor muscle training (PFMT) for stress/mixed, and bladder training for urgency/mixed, alongside lifestyle advice.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Classify:&lt;/strong&gt; stress (exertion/cough/laugh), urgency/OAB (urgency +/- frequency/nocturia), mixed (predominant symptom).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Baseline:&lt;/strong&gt; urine dip for blood/glucose/protein/leukocytes/nitrites; manage suspected UTI per UTI guidance.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Bladder diary:&lt;/strong&gt; encourage ≥3 days (include work/leisure days).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Examination (when indicated):&lt;/strong&gt; abdominal/pelvic exam to exclude mass/prolapse and assess atrophy; assess pelvic floor muscle contraction before supervised PFMT.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Consider PVR (bladder scan):&lt;/strong&gt; if voiding dysfunction symptoms or recurrent UTI.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Red flags / consider referral:&lt;/strong&gt; pain; voiding difficulty/retention; suspected fistula; neurological disease; faecal incontinence; pelvic mass; previous continence surgery/radiotherapy/pelvic cancer surgery.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Lifestyle:&lt;/strong&gt; reduce caffeine (OAB); optimise fluid intake; weight loss if BMI &gt;30; manage constipation; address chronic cough/smoking.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Stress or mixed (stress-predominant):&lt;/strong&gt; supervised PFMT for at least 3 months (typical: ≥8 contractions, 3 times/day). Continue if beneficial.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Urgency/OAB or mixed (urgency-predominant):&lt;/strong&gt; bladder training for at least 6 weeks. If insufficient benefit and frequency troublesome, consider adding an OAB medicine alongside bladder training (consider anticholinergic burden/cognition risk).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;GSM/atrophy:&lt;/strong&gt; consider vaginal oestrogen if OAB symptoms plus genitourinary symptoms/signs of menopause (check contraindications/local formulary).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Containment products:&lt;/strong&gt; may be used as a coping strategy pending treatment, an adjunct to therapy, or for long-term only after options explored; review at least annually if used long-term.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Consider specialist referral:&lt;/strong&gt; persisting bladder/urethral pain; voiding difficulty or suspected retention; suspected urogenital fistula; suspected neurological disease; faecal incontinence; benign pelvic mass; palpable bladder after voiding; previous continence surgery; previous pelvic cancer surgery/radiotherapy.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Suspected urinary tract cancer:&lt;/strong&gt; refer per local NG12 suspected cancer pathway for haematuria or recurrent/persistent unexplained UTI.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Overactive bladder:&lt;/strong&gt; if OAB medicines are not successful or not tolerated, refer to secondary care to consider further options.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Stress UI:&lt;/strong&gt; if conservative management fails and patient wants to discuss surgery, refer to appropriate continence/urogyn/urology service (local model).&lt;/li&gt;
&lt;/ul&gt;

&lt;p class=&quot;small&quot;&gt;&lt;strong&gt;Referral letter: suggested information (triage metrics)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Symptom category (stress/urgency/mixed) + predominant symptom; duration; impact; triggers; pad use; nocturia.&lt;/li&gt;
  &lt;li&gt;Urine dip/MSU result; recurrent UTI history; haematuria present/absent.&lt;/li&gt;
  &lt;li&gt;Bladder diary (3 days): frequency/volume, urgency, incontinence episodes, fluid/caffeine intake.&lt;/li&gt;
  &lt;li&gt;Exam findings if done: prolapse present/absent; pelvic mass excluded; atrophy/GSM signs; pelvic floor contraction.&lt;/li&gt;
  &lt;li&gt;Treatments tried: PFMT (duration/supervised?), bladder training (duration), lifestyle measures, meds tried and adverse effects.&lt;/li&gt;
  &lt;li&gt;Red flags: pain; voiding difficulty/retention; neurological symptoms; faecal incontinence; previous pelvic surgery/radiotherapy/continence surgery.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;Uncomplicated stress/urgency/mixed urinary incontinence without red flags can usually start with conservative management in primary care (PFMT/bladder training/lifestyle) with planned review.&lt;/li&gt;
  &lt;li&gt;Do not refer solely for containment product requests without also offering assessment and conservative options (service availability permitting).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;NICE NG123. Urinary incontinence and pelvic organ prolapse in women: management. https://www.nice.org.uk/guidance/ng123 (retrieved 2026‑02‑09)&lt;/li&gt;
  &lt;li&gt;NICE NG123 recommendations (assessment, non-surgical management, medicines, referral). https://www.nice.org.uk/guidance/ng123/chapter/recommendations (retrieved 2026‑02‑09)&lt;/li&gt;
  &lt;li&gt;NICE NG12. Suspected cancer recognition and referral (urological cancers). https://www.nice.org.uk/guidance/ng12 (retrieved 2026‑02‑09)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Urinary incontinence (women)</h3>

              <h4>Background</h4>
              <ul>
                <li>Categorise as <strong>stress</strong>, <strong>urgency urinary incontinence/overactive bladder (OAB)</strong>, or <strong>mixed</strong>; in mixed, treat the <strong>predominant symptom</strong> first.</li>
                <li>First-line is usually conservative management (PFMT / bladder training + lifestyle).</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>Symptoms:</strong> stress (leak with cough/laugh/exertion), urgency/OAB (urgency +/- frequency/nocturia), mixed (predominant symptom). Document impact.</li>
                <li><strong>Baseline tests:</strong> urine dipstick in all (blood, glucose, protein, leukocytes, nitrites). MSU culture guided by symptoms + dip results.</li>
                <li><strong>Bladder diary:</strong> ask for ≥3 days (include work/leisure days).</li>
                <li><strong>Examination:</strong> abdominal/pelvic exam when needed to exclude pelvic mass/prolapse/other pathology; consider GSM/atrophy. Assess pelvic floor muscle contraction before supervised PFMT.</li>
                <li><strong>Consider post-void residual (bladder scan):</strong> if voiding dysfunction symptoms or recurrent UTI.</li>
                <li><strong>Do not routinely:</strong> imaging (except residual), cystoscopy, pad tests, or urodynamics in straightforward primary stress UI prior to surgery (specialist decision).</li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li><strong>Lifestyle:</strong> reduce caffeine (OAB); fluid optimisation; weight loss if BMI &gt;30; constipation management; address chronic cough/smoking.</li>
                <li><strong>Stress (or stress-predominant mixed):</strong> supervised PFMT for ≥3 months (typical: ≥8 contractions, 3 times/day). Continue if beneficial.</li>
                <li><strong>Urgency/OAB (or urgency-predominant mixed):</strong> bladder training for ≥6 weeks. If insufficient benefit and frequency is troublesome, consider adding an OAB medicine alongside bladder training (counsel: benefits may take ≥4 weeks; consider anticholinergic burden/cognitive risk).</li>
                <li><strong>GSM/atrophy:</strong> consider vaginal oestrogen if OAB symptoms plus genitourinary symptoms/signs of menopause (check contraindications and local formulary).</li>
                <li><strong>Containment products:</strong> coping strategy pending treatment; adjunct; or long-term only after treatment options explored (review at least annually if long-term).</li>
              </ul>

              <h4>Who to refer</h4>
              <ul>
                <li><strong>Consider specialist referral</strong> (continence/urogyn/urology depending on local model) if: persisting bladder/urethral pain; voiding difficulty/retention; suspected fistula; suspected neurological disease; associated faecal incontinence; pelvic mass; previous continence surgery; previous pelvic cancer surgery; previous pelvic radiotherapy.</li>
                <li><strong>Suspected cancer referral (NG12/local pathway):</strong> haematuria or recurrent/persistent unexplained UTI.</li>
                <li><strong>OAB:</strong> if medicines tried but not successful or not tolerated → secondary care for further options.</li>
                <li><strong>Stress UI:</strong> if conservative management fails and patient wants to discuss surgery → refer for specialist assessment and shared decision-making.</li>
              </ul>

              <h4>Referral letter: suggested information (triage metrics)</h4>
              <ul>
                <li>Category + predominant symptom; duration; impact; triggers; nocturia; pad use.</li>
                <li>Urine dip + MSU (if done); haematuria present/absent; recurrent UTI history.</li>
                <li>3‑day bladder diary summary (frequency, volumes, urgency and incontinence episodes; fluids/caffeine).</li>
                <li>Exam findings if performed: prolapse present/absent; pelvic mass excluded; GSM/atrophy signs; pelvic floor contraction.</li>
                <li>Treatments tried: PFMT (duration, supervised?), bladder training duration, lifestyle changes; medicines tried and adverse effects.</li>
                <li>Red flags / relevant history: voiding difficulty/retention symptoms; neurological symptoms; faecal incontinence; previous pelvic surgery/radiotherapy/continence surgery.</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>Uncomplicated stress/urgency/mixed urinary incontinence without red flags: start conservative management in primary care with planned review.</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm D&amp;G referral destination(s): continence nurse / pelvic floor physio / urogynaecology / urology (and how to choose by symptom type).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether there is a direct pelvic floor physio pathway (and any referral form/thresholds).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm local formulary first-line OAB medicines and any anticholinergic-burden guidance used locally (incl. older/frail patients).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm expectations for what primary care should include before referral (e.g., bladder diary mandatory; PFMT duration; trial of bladder training/meds; PVR threshold/when to request).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm local approach to women with urinary symptoms + prolapse (single combined pelvic floor service vs separate routes).</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ol>
                <li>NICE NG123. Urinary incontinence and pelvic organ prolapse in women: management. <a href="https://www.nice.org.uk/guidance/ng123">https://www.nice.org.uk/guidance/ng123</a> (retrieved 2026‑02‑09)</li>
                <li>NICE NG123 recommendations. <a href="https://www.nice.org.uk/guidance/ng123/chapter/recommendations">https://www.nice.org.uk/guidance/ng123/chapter/recommendations</a> (retrieved 2026‑02‑09)</li>
                <li>NICE NG12. Suspected cancer: recognition and referral. <a href="https://www.nice.org.uk/guidance/ng12">https://www.nice.org.uk/guidance/ng12</a> (retrieved 2026‑02‑09)</li>
                <li>NICE TA999. Vibegron for treating symptoms of overactive bladder (where antimuscarinics unsuitable/ineffective/unacceptable). <a href="https://www.nice.org.uk/guidance/ta999">https://www.nice.org.uk/guidance/ta999</a> (retrieved 2026‑02‑09)</li>
                <li>NICE TA290. Mirabegron for treating symptoms of overactive bladder. <a href="https://www.nice.org.uk/guidance/ta290">https://www.nice.org.uk/guidance/ta290</a> (retrieved 2026‑02‑09)</li>
              </ol>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
